Assay Precision Testing

FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated ...

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

一些您可能无法访问的结果已被隐去。